2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

 

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
H

Where Are We Going With Biosimilars in Oncology? Data Based on the New Frontier in HER2+ Tumors - Trastuzumab

By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Hope Rugo
By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Hope Rugo
832 views
September 10, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Biosimilars
17:28

Overview of Biosimilars in Oncology: What Are They and How They Fit …

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

M. Aapro

393 views
19:47

Biosimilars in Supportive Care: Implementation, Safety, Efficacy, an…

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

E. Foreman

20 views
15:44

2019 Overview of Current Guidelines on the Use of Biosimilars

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

H. Dhillon

212 views
21:12

Where Are We Going With Biosimilars in Oncology? Data Based on the N…

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

H. Rugo

832 views